Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

HERON THERAPEUTICS, INC. /DE/ (HRTX) Form 8-K — Aug 14, 2026

$HRTXForm 8-KItems 1.01, 3.03, 9.01Filed Aug 14, 2026, 4:30 PM ET0001193125-26-352403Original filing

On August 13, 2026, Heron Therapeutics entered into Amendment No. 1 to its Tax Benefit Preservation Plan, extending the plan's Final Expiration Date from August 14, 2026 to August 14, 2029. The plan was originally adopted on August 14, 2025 with Computershare Trust Company, N.A. acting as rights agent.

Key figures

Amendment effective date
August 13, 2026
New final expiration date
August 14, 2029
Plan original adoption date
August 14, 2025
Prior final expiration date
August 14, 2026

Price after filing

1 day: +0.7%7 days: -4.8%30 days: -5.7%

Close on the filing date to close N calendar days later (from $0.33). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.